LOTUSEYE (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Lotus Eye Hospital and Institute Limited |
|||
|
Price: ₹66.83 | ||
| 52 Week Low: ₹48.50 52 Week High: ₹95.60 |
|||
| Market Capital: 138.42 Crore (Smallcap) | |||
| Healthcare -> Medical Care Facilities | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: LOTUSEYE Share Price Target For 2024
- 1.1.1: LOTUSEYE Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: LOTUSEYE Share Price Target For 2025
- 1.2.1: LOTUSEYE Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: LOTUSEYE Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: LOTUSEYE Brief Company Overview
- 4: LOTUSEYE Financial Performance
- 4.0.1: Is LOTUSEYE A Good Buy For Long Term?
To predict the LOTUSEYE's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
LOTUSEYE Share Price Target For 2024
The line chart displays the monthly closing prices of LOTUSEYE with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for LOTUSEYE shares in 2024, see the table below.
LOTUSEYE Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 70.11 (+4.9%) | Technical Indicator: MA50 |
| 2024 Target 2 | 69.34 (+3.75%) | Price Action: 19 Dec 2024 Low |
| 2024 Target 1 | 68.59 (+2.63%) | Technical Indicator: MA150 |
| Current Price | 66.83 | LOTUSEYE's share price as of 23 Dec 2024 |
| Stop Loss 1 | 66.0 (-1.25%) | Price Action: 30 Oct 2024 Low |
| Stop Loss 2 | 65.22 (-2.41%) | Price Action: Jan 2023 Low |
| Stop Loss 3 | 64.4 (-3.64%) | Price Action: 19 Nov 2024 Low |
Short-Term Technical Outlook
Current Technical Position: LOTUSEYE is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹69.99 serves as the nearest technical reference point.
Historical Returns: 3-month: -21.36% | 6-month: +20.32% | 1-year: -18.66%
LOTUSEYE Share Price Target For 2025
The line chart displays the monthly closing prices of LOTUSEYE with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for LOTUSEYE shares in 2025, see the table below.
LOTUSEYE Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 99.24 (+48.49%) | Price Action: Chart |
| 2025 Target 2 | 97.39 (+45.72%) | Fibonacci Extension Level 64.90% |
| 2025 Target 1 | 95.59 (+43.03%) | Fibonacci Extension Level 100.00% |
| Current Price | 66.83 | LOTUSEYE's share price as of 23 Dec 2024 |
| Stop Loss 1 | 57.66 (-13.73%) | Price Action: Apr 2023 Low |
| Stop Loss 2 | 57.08 (-14.59%) | Price Action: Chart |
| Stop Loss 3 | 56.05 (-16.14%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: LOTUSEYE is currently trading at 38.9% of its 52-week range (₹48.5 - ₹95.6).
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -18.66% | 3-year: +32.45% | 5-year: +206.97%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
LOTUSEYE Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹66.83 | ||
| 2024 | ₹71.15 | +6.46% | ₹72.22 |
| 2025 | ₹73.77 | +3.68% | ₹75.89 |
| 2026 | ₹77.62 | +5.21% | ₹78.78 |
| 2027 | ₹74.43 | -4.1% | ₹79.16 |
| 2028 | ₹75.79 | +1.82% | ₹82.44 |
| 2029 | ₹83.83 | +10.6% | ₹85.71 |
| 2030 | ₹86.46 | +3.13% | ₹88.98 |
| 2031 | ₹90.53 | +4.7% | ₹91.89 |
| 2032 | ₹86.41 | -4.55% | ₹92.26 |
| 2033 | ₹87.61 | +1.38% | ₹95.53 |
| 2034 | ₹96.51 | +10.15% | ₹98.81 |
| 2035 | ₹99.16 | +2.74% | ₹100.65 |
| 2036 | ₹103.44 | +4.31% | ₹104.99 |
| 2037 | ₹98.40 | -4.87% | ₹99.88 |
| 2038 | ₹99.43 | +1.04% | ₹100.92 |
| 2039 | ₹104.72 | +5.32% | ₹106.29 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
LOTUSEYE Brief Company Overview
Lotus Eye Hospital and Institute Limited: Leading Eye Care Provider in India Established in 1997, Lotus Eye Hospital and Institute Limited has emerged as a renowned eye care provider in India. Headquartered in Coimbatore, the company offers a comprehensive range of eye care...
services, including cataract and refractive surgery, retinal disease and diabetic eye care, glaucoma, neuro ophthalmology, ocular prosthesis, and binocular vision. Over the years, Lotus Eye Hospital has expanded its offerings to include optical fellowship courses and DNB training services. The company's commitment to providing quality eye care is reflected in its modern, state-of-the-art facilities and a team of highly skilled professionals. With a strong focus on innovation, Lotus Eye Hospital has introduced advanced techniques and technologies, such as zyoptix ultimate and ocular prosthesis, to cater to the diverse needs of its patients. The company's reputation for excellence has earned it a loyal customer base and a strong presence in the Indian eye care market.LOTUSEYE Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 138.42 Crore | Market valuation of LOTUSEYE's shares. |
| Revenue (TTM) | 48.53 Crore | Total revenue generated by LOTUSEYE over the past twelve months. |
| Net Income (TTM) | +2.15 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +4.71% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +4.43% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+2.6% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-54.91% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
1.86 | Company's total debt divided by total shareholder equity. |
| Total Debt | 1.11 Crore | Sum of LOTUSEYE's current & long-term financial obligations. |
| Total Cash | 6.92 Crore | Total amount of liquid funds available to LOTUSEYE. |
| Beta | 0.38 | Beta is less than 1 indicating that the LOTUSEYE's price is less volatile than the market. |
Is LOTUSEYE A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
